Boehringer Sued Over $120M Pay-For-Delay On Stroke Drug
Miami-Luken Inc., a wholesaler to pharmacies, accused Boehringer Ingelheim Pharmaceuticals Inc. of orchestrating a $120 million pay-for-delay deal to keep generic versions of its stroke prevention medication off the market, according...To view the full article, register now.
Already a subscriber? Click here to view full article